Cargando…
Micropuncture closure following high density microarray patch application in healthy subjects
BACKGROUND: The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907643/ https://www.ncbi.nlm.nih.gov/pubmed/35064694 http://dx.doi.org/10.1111/srt.13131 |
_version_ | 1784884212760838144 |
---|---|
author | Henricson, Joakim Muller, David A. Baker, S. Ben Iredahl, Fredrik Togö, Totte Anderson, Chris D. |
author_facet | Henricson, Joakim Muller, David A. Baker, S. Ben Iredahl, Fredrik Togö, Totte Anderson, Chris D. |
author_sort | Henricson, Joakim |
collection | PubMed |
description | BACKGROUND: The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a local innate physical inflammatory response to adjuvant the vaccination process. The application process needs to induce levels of reactivity, which are acceptable to the vaccine, and from which the skin promptly recovers. MATERIALS AND METHODS: 1 × 1 cm HD‐MAP patches containing 5000, 250‐μm long microprojections were applied to the skin in 12 healthy volunteers. The return of skin barrier function was assessed by transepidermal water loss (TEWL) and reaction to topical histamine challenge. RESULTS: Skin barrier recovery by 48 h was confirmed for all HD‐MAP sites by recovered resistance to the effects of topical histamine application. CONCLUSIONS: Our previous observation, that the barrier disruption indicator TEWL returns to normal by 48 h, is supported by this paper's demonstration of return of skin resistance to topical histamine challenge in twelve healthy subjects. |
format | Online Article Text |
id | pubmed-9907643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99076432023-04-13 Micropuncture closure following high density microarray patch application in healthy subjects Henricson, Joakim Muller, David A. Baker, S. Ben Iredahl, Fredrik Togö, Totte Anderson, Chris D. Skin Res Technol Original Articles BACKGROUND: The high‐density microarray patch (HD‐MAP) promises to be a robust vaccination platform with clear advantages for future global societal demands for health care management. The method of action has its base not only in efficient delivery of vaccine but also in the reliable induction of a local innate physical inflammatory response to adjuvant the vaccination process. The application process needs to induce levels of reactivity, which are acceptable to the vaccine, and from which the skin promptly recovers. MATERIALS AND METHODS: 1 × 1 cm HD‐MAP patches containing 5000, 250‐μm long microprojections were applied to the skin in 12 healthy volunteers. The return of skin barrier function was assessed by transepidermal water loss (TEWL) and reaction to topical histamine challenge. RESULTS: Skin barrier recovery by 48 h was confirmed for all HD‐MAP sites by recovered resistance to the effects of topical histamine application. CONCLUSIONS: Our previous observation, that the barrier disruption indicator TEWL returns to normal by 48 h, is supported by this paper's demonstration of return of skin resistance to topical histamine challenge in twelve healthy subjects. John Wiley and Sons Inc. 2022-01-22 /pmc/articles/PMC9907643/ /pubmed/35064694 http://dx.doi.org/10.1111/srt.13131 Text en © 2022 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Henricson, Joakim Muller, David A. Baker, S. Ben Iredahl, Fredrik Togö, Totte Anderson, Chris D. Micropuncture closure following high density microarray patch application in healthy subjects |
title | Micropuncture closure following high density microarray patch application in healthy subjects |
title_full | Micropuncture closure following high density microarray patch application in healthy subjects |
title_fullStr | Micropuncture closure following high density microarray patch application in healthy subjects |
title_full_unstemmed | Micropuncture closure following high density microarray patch application in healthy subjects |
title_short | Micropuncture closure following high density microarray patch application in healthy subjects |
title_sort | micropuncture closure following high density microarray patch application in healthy subjects |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907643/ https://www.ncbi.nlm.nih.gov/pubmed/35064694 http://dx.doi.org/10.1111/srt.13131 |
work_keys_str_mv | AT henricsonjoakim micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects AT mullerdavida micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects AT bakersben micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects AT iredahlfredrik micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects AT togototte micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects AT andersonchrisd micropunctureclosurefollowinghighdensitymicroarraypatchapplicationinhealthysubjects |